Last $118.62 USD
Change Today -0.95 / -0.79%
Volume 897.5K
AMGN On Other Exchanges
Symbol
Exchange
Hong Kong
Mexico
NASDAQ GS
Sao Paulo
Frankfurt
As of 11:55 AM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger M. Perlmutter M.D., Ph.D.

Executive Vice President and President of Merck Research Laboratories, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 36 board members in 2 different organizations across 8 different industries.

See Board Relationships
62$5,986,124
As of Fiscal Year 2013

Background*

Dr. Roger M. Perlmutter, M.D., Ph.D. has been Executive Vice President and President of Merck Research Laboratories at Merck & Co. Inc. since April 15, 2013. Dr. Perlmutter serves as Science Partner at The Column Group LLC. Dr. Perlmutter served as Consultant of Amgen Inc. since February 2012. He served as an Executive Vice President of Research and Development at Amgen Inc. from January 2001 to February 2012, where he oversaw its worldwide research and development operations. ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

Director
2000-2013
Former Director and Member of Corporate Governance & Nominating Committee
2012-2013
Former Director
2012-Present
Non-Executive Director
2012-N/A
Former Director and Member of Scientific Advisory Board

Education*

PhD 1979
Washington University, St. Louis
MD 1979
Washington University, St. Louis
Unknown/Other Education 1973
Reed College

Other Affiliations*

Annual Compensation*

Salary$711,538
Bonus$500,000
Total Annual Compensation$1,211,538

Stock Options*

Restricted Stock Awards$2,699,987
All Other Compensation$16,459
Unexercisable Options225,443
Unexercisable Options Value$1,142,996
Total Value of Options$1,142,996
Total Number of Options225,443

Total Compensation*

Total Annual Cash Compensation$1,851,697
Total Short Term Compensation$1,211,538
Other Long Term Compensation$2,716,446
Total Calculated Compensation$5,986,124
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMGN:US $118.60 USD -0.97

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.